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Abstract
Age-related decline in circulating levels of insulin-like growth factor (IGF)-1 is associated with reduced cognitive function,
neuronal aging, and neurodegeneration. Decreased mitochondrial function along with increased reactive oxygen species (ROS)
and accumulation of damaged macromolecules are hallmarks of cellular aging. Based on numerous studies indicating pleiotropic
effects of IGF-1 during aging, we compared the central and peripheral effects of circulating IGF-1 deficiency on tissue mito-
chondrial function using an inducible liver IGF-1 knockout (LID). Circulating levels of IGF-1 (~ 75%) were depleted in adult
male Igf1f/f mice via AAV-mediated knockdown of hepatic IGF-1 at 5 months of age. Cognitive function was evaluated at 18
months using the radial arm water maze and glucose and insulin tolerance assessed. Mitochondrial function was analyzed in
hippocampus, muscle, and visceral fat tissues using high-resolution respirometry O2K as well as redox status and oxidative stress
in the cortex. Peripherally, IGF-1 deficiency did not significantly impact muscle mass or mitochondrial function. Aged LID mice
were insulin resistant and exhibited ~ 60% less adipose tissue but increased fat mitochondrial respiration (20%). The effects on fat
metabolism were attributed to increases in growth hormone. Centrally, IGF-1 deficiency impaired hippocampal-dependent
spatial acquisition as well as reversal learning in male mice. Hippocampal mitochondrial OXPHOS coupling efficiency and
cortex ATP levels (~ 50%) were decreased and hippocampal oxidative stress (protein carbonylation and F2-isoprostanes) was
increased. These data suggest that IGF-1 is critical for regulating mitochondrial function, redox status, and spatial learning in the
central nervous system but has limited impact on peripheral (liver and muscle) metabolismwith age. Therefore, IGF-1 deficiency
with age may increase sensitivity to damage in the brain and propensity for cognitive deficits. Targetingmitochondrial function in
the brain may be an avenue for therapy of age-related impairment of cognitive function. Regulation ofmitochondrial function and
redox status by IGF-1 is essential to maintain brain function and coordinate hippocampal-dependent spatial learning. While a
decline in IGF-1 in the periphery may be beneficial to avert cancer progression, diminished central IGF-1 signaling may mediate,
in part, age-related cognitive dysfunction and cognitive pathologies potentially by decreasing mitochondrial function.
Highlights Circulating IGF-1 deficiency:
• Has pleiotropic effects on central and peripheral tissues.
• Induces impairments in hippocampal learning and memory.
• Decreases hippocampal mitochondrial oxygen coupling efficiency.
• Increases stress response and oxidative damage in brain.
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Introduction
Aging is associated with reductions in mitochondrially de-
rived energy production [1], global increases in oxidative load
(reviewed by [2, 3]), and a concomitant decline in correlates of
cognitive function, specifically neuronal and astroglial func-
tion [4–6]. Dysregulation of mitochondrial function, including
diminished ATP synthesis, excessive free radical production,
and apoptosis, is part of the etiology of many age-related
human diseases, including neurodegenerative disorders such
as Alzheimer’s disease [7, 8].
Insulin-like growth factor-1 (IGF-1) is a potent neurotroph-
ic factor that is abundantly expressed in the central nervous
system during embryonic development and peaks during pu-
berty, a period of rapid growth and development [9].
Subsequently, later in life, IGF-1 levels decline substantially
with age [10] both centrally (~ 30% decline) and peripherally
(~ 70% decline) [11]. IGF-1 is produced and secreted into the
bloodstream primarily by the liver in response to growth hor-
mone (GH) secreted by the anterior pituitary. IGF-1 produced
by the liver is transported by IGF-1 binding proteins (IGFBP)
and crosses the blood-brain barrier. In addition to circulating
IGF-1, this peptide is also produced locally in the brain and
other tissues and has autocrine/paracrine actions. IGF-1 ligand
binding to its cognate receptor, insulin-like growth factor re-
ceptor (IGFR), induces conformational changes that initiate
receptor autophosphorylation of the intracellular kinase do-
mains [12] that activate downstream signaling cascades in-
cluding the PI3K/AKT and MAPK pathways that drive cell
survival and growth [13].
The role of IGF-1 in cognitive and systemic aging is con-
troversial due, in part, to the pleiotropic effects of IGF-1
[14–17]. Models of early life IGF-1 deficiency by disruption
of either GH/IGF-1 axis or DAF2/insulin signaling have re-
ported increases in lifespan in nematodes, flies, and mice [18,
19]. Conversely, reduced IGF-1 has been associated with ox-
idative stress [20, 21] and increased risk of cardiovascular
disease [22, 23], stroke [24, 25], and cognitive decline [11,
14, 26, 27]. While reduction in IGF-1 peripherally protects
against the onset and progression of specific types of cancer
[14] and modestly increases lifespan in a sex-dependent man-
ner, deficiency of IGF-1 availability in the brain by ectopic
expression of IGF-1 binding protein (IGFBP-1) has been
shown to reduce astrocytic response to injury [28]. IGF-1
has also been shown to protect neurons against oxidative
stress via modulation of astrocytic responses [29, 30]. IGF-1
signaling regulates ATP production in aging mice [31] and has
recently been shown to affect mitochondrial dynamics in
astroglial cells [32]. However, the role of IGF-1 in regulating
mitochondrial function centrally and peripherally is not well
understood, and the mechanism by which IGF-1 mediates
cognitive performance and preserves peripheral tissue func-
tion remains controversial.
In this study, we investigated the central and peripheral
effects of circulating IGF-1 deficiency on tissue mitochondrial
function. We show that IGF-1 deficiency does not significant-
ly impact muscle mitochondrial function, although fat metab-
olism was increased. The latter could be attributed to increases
in growth hormone in this model that has been shown to
increase fat metabolism. More importantly, we show that cir-
culat ing IGF-1 deficiency significantly impaired
hippocampal-dependent spatial acquisition as well as reversal
learning in male mice. These behavioral data correlated with
decreased brain ATP levels and hippocampal mitochondrial
OXPHOS coupling efficiency. Furthermore, IGF-1 knock-
down increased hippocampal oxidative stress and stress-
related gene expression. These data suggest that IGF-1 is crit-
ical for mitochondrial function in the central nervous system
and coordinates spatial learning. IGF-1 deficiency with age
may increase sensitivity to damage in the brain and propensity
for cognitive deficits and targeting mitochondrial function in
the brain may be an avenue for therapy for age-related impair-
ment of cognitive function.
Materials and Methods
Animals
All procedures were approved by and followed the guidelines
of the Institutional Animal Care and Use Committee of
OUHSC. Only male mice were used in this study. Young
(4–6 months) C57Bl/6 and Igf1f/f (B6.129(FVB)-Igf1tm1Dlr/
J) mice were obtained from Jackson laboratories. Mice were
housed (3–4 per cage) in AllentownXJ cages with Anderson’s
Enrich-o-cob bedding (Maumee, OH). C57Bl/6 mice were
bred in house to generate experimental cohorts. These mice
were housed in the Rodent Barrier Facility (RBF) at OUHSC,
which is a specific pathogen-free (including helicobacter and
parvovirus) facility. Mice were bred on a 14-h light/10-h dark
cycle and weaned mice were maintained in a 12-h light/12-h
dark cycle at 21 °C and were given access to standard irradi-
ated bacteria-free rodent chow (5053 Pico Lab, Purina Mills,
Richmond, IN) and reverse osmosis filtered water ad libitum.
Liver IGF-1-Deficient (LID) Mice
Igf1f/f mice (C57Bl/6J background) were injected retro-
orbitally with AAV8-TBG-GFP (control mice) or AAV8-
TBG-GFP-CRE (LID mice) at 4–5 months of age as
Mol Neurobiol (2020) 57:1317–13311318
previously described [14]. Mice were housed and evaluated at
specific timepoints (18 months and 23–24 months chronolog-
ical age; Fig. 1a) for behavioral and molecular endpoints.
IGF-1 ELISA
Whole blood was isolated from the submandibular vein and
centrifuged (2500×g for 20 min at 4 °C), sera removed, and
frozen at – 80 °C until further analysis. IGF-1 concentrations
were quantified using Mouse IGF-1 Quantikine ELISA kit
(R&D Systems, Minneapolis, MN) as described previously
[14]. All analytes were measured in duplicate following the
manufacturers’ recommendations.
Glucose and Insulin Tolerance Test
Glucose tolerance test (GTT) was performed on control (n =
6) and LID (n = 8) mice at 1 year post knockdown (15-month
chronological age). Fasted mice (16 h) were orally adminis-
tered 1.5 g/kg of D-glucose (Sigma). Prior to and after glucose
administration, blood glucose levels were recorded from tail
vein at 0, 30, 60, 120, and 150 min. Mice were returned to
their home cages and allowed to recover for 1 week.
Subsequently, an insulin tolerance test (ITT) was per-
formed on the same mice. Mice were fasted for 5 h during
the day, then injected with 0.75 units/kg body weight of hu-
man insulin (Sigma) and blood glucose measured as before at
0, 15, 30, 60, and 120 min from tail vein. Area under the curve
(AUC) was determined for eachmouse using GraphPad Prism
version 7.0b for Mac OSX.
Energy Charge Measurements and Glutathione Redox
Status
Mice were rapidly decapitated, their brain exposed within the
skull, and whole heads were flash frozen in liquid nitrogen (≤
15 s) to avoid degradation of ATP and other metabolites.
Control and Igf1 knockout (LID) brains and eWAT (n =
6/group) were then scraped under liquid nitrogen and proc-
essed. Samples were extracted with 300 μl of 300 mM potas-
sium hydroxide. The resulting extract was centrifuged at
20,000×g for 15 min, then filtered and resolved by high-
performance liquid chromatography (Shimadzu LC-20A
Fig. 1 Liver IGF-1 deficiency (LID) increases insulin resistance. a
Experimental timeline of circulating IGF-1 deficiency induced by liver-
specific AAV8-TBG-Cre (LID) or AAV8-TBG GFP (GFP) illustrating
the timepoints for induction and functional analyses. b Circulating IGF-1
in the serum is significantly reduced in the LID (n = 12) compared with
GFP (n = 6) mice at 18 months of age. c Body mass was not different
between GFP (green) and LID (blue) mice at 18 months and 24 months
and was comparable with young WT (black) mice (6-month reference
group; n = 6). d Glucose tolerance test (GTT) and e insulin tolerance test
(ITT) in 18-month GFP and LID mice and f area under the curve (AUC)
for insulin tolerance test (n = 6–8). GTT/ITT were analyzed by two-way
ANOVA with Sidak’s post hoc test (*p < 0.05). Serum IGF-1 and ITT
AUC were compared with two-tailed student’s t test (*p < 0.05). Data are
represented as the mean ± SEM. Radial arm water maze (RAWM); oxi-
dative phosphorylation (OXPHOS)
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High Precision Binary Gradient HPLC system; Shimadzu,
Kyoto, Japan). A UV/VIS diode array spectrometer was used
to detect AMP, ADP, and ATP at 254 nm and quantified on the
basis of the integrated area of standards [33]. Energy charge
was calculated by using the equation: ([ATP] + 0.5[ADP])/
([ATP] + [ADP] + [AMP]).
The intracellular ratio of NAD+ to NADH in cell lysates
was measured in cortex by using an enzyme recycling reaction
to quantitate NADH absorbance in accordance with the in-
structions of the manufacturer (BioVision, Inc., Milpitas,
CA, USA) [33]. Oxidized and reduced glutathione were mea-
sured spectrophotometrically in both cortex and eWAT (Tecan
US) by using an enzymatic recycling method to quantify the
production of 5-thio-2-nitrobenzoic acid (TNB) generated
from the reaction of reduced glutathione (GSH) with 5′-5′
dithio-bis-2 (nitrobenzoic acid) (DTNB) in accordance with
the instructions of the manufacturer (Cayman Chemicals
Company).
Hippocampus Mitochondrial Isolation and Muscle
and Fat Biopsy preparation
Mice (18 months) were rapidly decapitated and hippo-
campi were dissected from the brain into mitochondria
isolation buffer-A (10 mM HEPES, 250 mM D-
Mannitol, 75 mM sucrose, 100 μM EDTA, 500 μM
EGTA, 0.1% BSA, and protease inhibitor cocktail
(Roche)). Two hippocampi from one mouse were pooled
for n = 1. Mitochondria were isolated as previously de-
scribed [32]. Hippocampi were homogenized with 30
strokes with a Dounce homogenizer. The homogenate
was spun at 1500×g for 10 min to pellet nuclei. The
resulting supernatant was spun at 20,000×g for 20 min
and the resulting mitochondrial pellet was resuspended
in assay buffer [125 mM KCl, 10 mM HEPES, 5 mM
MgCl2, 2 mM K2HPO4, pH 7.44] for analysis by high-
resolution respirometry (HRR). Protein concentration was
determined by the Bio-Rad DC assay (Bio-Rad, Hercules,
CA).
Muscle fiber and fat biopsies were isolated from young (6
months) and aged control and LID mice (24 months). Red
gastrocnemius muscle fibers (~ 3–5 mg) were separated in
buffer X containing (in mM) 7.23 K2EGTA, 2.77
CaK2EGTA, 20 imidazole, 0.5 DTT, 20 taurine, 5.7 ATP,
14.3 PCr, 6.56 MgCl2–6H2O, and 50 K-MES (pH 7.1). The
fibers were permeabilized in buffer X with 30 μg/ml saponin,
washed 3 times for 5 min in buffer Z containing (in mM) 105
K-MES, 30 KCl, 10 K2HPO4, 5 MgCl2–6H2O, 0.5 mg/ml
bovine serum albumin (BSA), and 0.1 EGTA (pH 7.1), then
loaded in the O2K. eWAT (~ 50 mg) was sliced into ~ 1 mm3
pieces and loaded directly into the O2K. Mitochondria (100
μg) isolated from hippocampi were loaded directly into the
O2K.
High-Resolution Respirometry and Fluorometry
We simultaneously probed oxygen consumption rate (OCR)
and hydroperoxide production rate in permeabilized gastroc-
nemius muscle fibers, epididymal white adipose tissue
(eWAT) biopsies, and isolated hippocampus mitochondria
using HRR (OROBOROS Instruments, Innsbruck, Austria)
and the O2K-Fluo LED2-Module Fluorescence-Sensor
Green with the fluorogenic probe Amplex UltraRed as previ-
ously described [34, 35]. Hydroperoxide groups, including
hydrogen peroxide and lipid hydroperoxides, interact with
Amplex UltraRed in a reaction catalyzed by horseradish per-
oxide to form the fluorescent compound resorufin [36]. The
rate of increase in fluorescence corresponds to the rate of
hydroperoxide production. The fluorescent signal was con-
verted to nanomolar H2O2 via a standard curve established
on each day of experiments. Background resorufin production
was subtracted from each measurement. Measurements were
performed in buffer Z at 37 °C containing 10 μM Amplex®
UltraRed (Molecular Probes, Eugene, OR), 1 U/ml horserad-
ish peroxidase (HRP), 12.5 U/ml superoxide dismutase
(SOD), and blebbistatin (25 μM).
We measured both OCR and hydroperoxide production
rate during sequential addition of sample, complex I substrates
(10 mM glutamate and 2 mMmalate), 2.5 mMADP, complex
II substrate (10 mM succinate), complex I inhibitor (1 μM
rotenone), complex III inhibitor (1 μM Antimycin A), and
complex IV substrates (5 mM ascorbate and 0.5 mM
TMPD). We normalized the OCR using non-mitochondrial
respiration after addition of antimycin A. LEAK state respira-
tion is the oxygen consumed in the presence of substrates but
absence of ADP to maintain the mitochondrial membrane
potential against protons that leak through the inner mem-
brane. Oxidative phosphorylation (OXPHOS) capacity is the
maximum ability to consume oxygen with supraphysiological
complex I and II substrates and ADP [37]. Data for OCR and
hydroperoxide production rate were normalized by wet
weight for muscle fibers, wet weight for fat biopsies, and
microgram of protein for isolated hippocampus mitochondria
determined by Bradford protein assay.
Targeted Quantitative Proteomics
Frozen mouse brain hippocampi were processed for GFP and
LID mice (n = 6). The tissues were homogenized in RIPA
buffer and a volume equivalent to 100 μg protein was taken
for analysis as previously described [38]. The samples were
analyzed on a TSQ Vantage triple quadrupole mass spectrom-
etry system with HPLC Eksigent splitless nanoflow. A BSA
internal standard was added for quantification, and the mass
spectrometer was operated in selected reaction monitoring
mode to analyze two peptides per protein. Data were analyzed
using the program SkyLine, and the response for each protein
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was calculated as the geometric mean of the two peptide area
normalized to the response for the BSA standard. The princi-
pal component analysis (PCA) plot was generated using
ClustVis with default settings (Row scaling = unit variance
scaling, PCA method = SVD with imputation, clustering dis-
tance for rows = correlation, clustering method for rows =
average, tree ordering for rows = tightest cluster first) [39].
Additional methodological details are available as supplemen-
tal methods.
F2-Isoprostane Quantification
Levels of F2-isoprostanes in cortex were determined by a pre-
viously described method with minor modifications [40].
Briefly, 200 mg of cortex was homogenized in 10 ml of ice-
cold Folch solution (CHCl3:MeOH, 2:1) containing butylated
hydroxytoluene (BHT). The mixture was incubated at room
temperature for 30 min. Two milliliters of 0.9% NaCl (w/v)
was added and mixed. The homogenate was centrifuged at
3000×g for 5 min at 4 °C. The aqueous layer was discarded,
while the organic layer was secured and evaporated to dryness
under N2 at 37 °C. Esterified F2-isoprostanes were extracted
and quantified by gas chromatography-mass spectrometry
using the internal standard [2H4]8-Iso-PGF2α, which was
added to the samples at the beginning of extraction to correct
yield of the extraction process. The level of F2-isoprostanes in
cortex was expressed as nanograms of 8-Iso-PGF2α, per gram
of mass.
Protein Carbonylation
Cortex protein carbonyls were measured as previously de-
scribed in skeletal muscle [41, 42]. Briefly, frozen cortex
was homogenized in sodium phosphate buffer. The hydrazine
reagent, fluorescein-5-thiosemicarbazide (FTC, Molecular
Probes, Eugene, OR, USA) (1 mM), was added and incubated
for 2 h at 37 °C in the dark. The excess unreacted FTC was
removed and equal amounts of protein were loaded on a 12%
sodium dodecyl sulfate polyacrylamide gel electrophoresis to
resolve the FTC-labelled proteins. A fluorescence scan of the
gel was used to measure the amount of bound FTC, and the
gel was stained with Coomassie blue. The carbonyl content of
the protein samples was expressed as the ratio of FTC fluo-
rescence (carbonyls) to Coomassie blue absorption (protein
concentration).
Radial Arm Water Maze (RAWM)
Mice (young and old C57Bl/6; n = 10/group) were tested for
spatial learning using an 8-arm radial arm water maze during
the morning hours. Mice were given 8 times for 60-s trials a
day for 3 days to find a hidden platform in one arm of an 8-arm
radial arm water maze that is 67 cm in diameter filled with an
opaque liquid. Animals were randomly placed in an arm other
than the target arm. Mice were guided to the platform if they
failed to find the target at the end of each 60-s trial. Animal
movements in the maze were recorded by a camera and
tracked using an automated tracking system (Noldus
Ethovision XT 11, Wageningen, Netherlands). The number
of errors (no. of entries into incorrect arms) and path length
(cm; total distance travelled) to target were recorded. An error
was counted when an animal had traversed 2/3 the length of
the arm that did not have the platform. Mice were tested dur-
ing the day (in the morning hours) for 3 days to find a hidden
platform in one arm (4 times 60-s trials), following which they
were returned to their home cage. One week later (day 10), the
ability of the mice to remember the position of the platform
was assessed with 4 times 60-s trials. The next day (day 11),
the platform was moved to a new location and mice were
tested again with 8 times for 60-s trials to relearn a new posi-
tion (extinction).
Statistical Analyses
All experiments were performed in multiple independent repli-
cates per group as described for each experiment. Statistical dif-
ferences between experimental groups for RAWM experiments
were analyzed using a multivariate repeated measures ANOVA
followed by Dunnett’s post hoc test. Data are represented as the
mean ± SEM. Significance is indicated by p valuemeasurements
with a p < 0.05 considered significant: *p < 0.05; **p < 0.01;
***p < 0.001. All other statistical methodswere performed using
GraphPad Prism version 7.0b for Mac OS X. Statistical signifi-
cance for experiments with two groups was determined using
unpaired two-tailed student’s t test with p < 0.05 considered
significant. Statistical significance for experiments with three
groups was determined using one-way ANOVA with Tukey’s
post hoc test where p < 0.05 is considered significant. Linear
regression was determined using GraphPad Prism. Statistical sig-
nificance for protein content by mass spectrometry was assessed
by one-way ANOVAwith Tukey’s post hoc test and Benjamini-
Hochberg correction. For the quantitative mass spectrometry,
energy charge measurements and glutathione redox status, and
F2-isoprostane quantification, the Grubb’s outlier test was used to
control for outliers in the data. For data sets with statistically
different variance, the variance was normalized by transforming
the data sets before running tests for statistical difference.
Results
Liver IGF-1 Deficiency Increases Insulin Resistance
To understand the role of IGF-1 deficiency in adulthood on
central and peripheral tissue metabolic functions, we knocked
down liver production of IGF-1 at 4–5 months of age. AAV8-
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TBG-Cre or AAV8-TBG-GFP were injected in Igf1f/f male
mice as previously described [14]. The timeline for the exper-
iment is outlined in Fig. 1a. Functional and biochemical end-
points were assessed at 18 months and 24 months chronolog-
ical age as illustrated. Cognitive testing and further analyses
on the brain were conducted at 18 months based on previous
studies that showed a decline in hippocampal neurogenesis by
18 months which persisted up to 28 months that was amelio-
rated by IGF-1 infusion [43]. Mitochondrial functional testing
on muscle and fat tissue were conducted at approximately 24
months, since previous studies on aged mice and with IGF-1
transgene expression in skeletal muscle have typically looked
at 22–24-month mice [44].
Levels of IGF-1 in the serum of LID mice were significant-
ly lower (~ 70% reduction; p < 0.001) than aged matched
control (GFP) mice at 18 months of age (~ 1 year of knock-
down; Fig. 1b). Body mass was not significantly different in
either group at 18months and 24months, but there was a trend
for lower body weight in the LID mice at 24 months (Fig. 1c).
Control 6-month C57Bl/6J mice were used as a reference
group for body weight comparisons. We then tested whether
IGF-1 deficiency had any effect on glucose or insulin process-
ing. No differences in glucose tolerance between the two
groups (Fig. 1d) were observed; however, LID mice were
more insulin resistant (p < 0.05) than the age matched control
(GFP) mice (Fig. 1e, f). Insulin resistance may result from
increased production of GH in this model [14, 45, 46] as a
compensatory mechanism for reduced feedback inhibition by
IGF-1.
IGF-1 Deficiency Does Not Alter Age-Related Changes
in Muscle Mass or Mitochondrial Function
The GH/IGF-1 axis regulates post-natal body growth and the
proportional increase in muscle mass, which is evident from
the reduced body/muscle size in early life knockouts of GH
[47–49] or IGF-1 [50, 51]. We therefore investigated whether
circulating IGF-1 deficiency had any effects on muscle mass
in aged mice. Actual body mass and normalized hind limb
muscle mass declines with age in the mouse gastrocnemius
and quadriceps muscles; however, we observed no differences
in muscle mass caused by IGF-1 deficiency (Fig. 2a, b).
IGF-1 has been shown to be essential for mitochondrial
biogenesis and turnover in cancer cells [52] and plays a pro-
tective role in regulating mitochondrial function [53–55]. We
therefore examined whether circulating IGF-1 deficiency in-
fluenced muscle mitochondrial function. We simultaneously
probed oxygen consumption rate (OCR) and hydroperoxide
production rate in permeabilized gastrocnemius muscle fibers
using the fluorogenic probe Amplex UltraRed in O2K HRR.
Hydroperoxide groups, including hydrogen peroxide and lipid
hydroperoxides, interact with Amplex UltraRed in a reaction
catalyzed by horseradish peroxide to form the fluorescent
compound resorufin [36]. The rate of increase in fluorescence
corresponds to the rate of hydroperoxide production. We mea-
sured OCR and hydroperoxide production rate during sequen-
tial addition of sample, complex I substrates (glutamate and
malate), ADP, complex II substrate (succinate), complex I
inhibitor (rotenone), complex III inhibitor (antimycin A),
and complex IV substrates (ascorbate and TMPD).
No significant difference was observed in oxygen con-
sumption rate, though there is a non-significant decrease in
OXPHOS capacity observed in both 24-month GFP and
LID muscle fibers (Fig. 2c). We observed a significant de-
crease in hydroperoxide production rate under certain condi-
tions in muscle fibers from 24-month GFP and LID mice, but
there were no differences in hydroperoxide production capa-
bilities following ETC inhibitors as a result of IGF-1 deficien-
cy (Fig. 2d). Plotting OXPHOS capacity versus normalized
gastrocnemius mass reveals a significant correlation between
OXPHOS capacity and gastrocnemius mass (Fig. 2e). Thus,
the age-related decline with OXPHOS capacity (GFP and LID
mice) parallels a decline in gastrocnemius muscle mass. We
previously reported no significant difference in hydroperoxide
production capability in aged gastrocnemius fibers [34].
Analyzing hydroperoxide production as a percentage of oxy-
gen consumed revealed no significant difference between
groups, suggesting that decreased hydroperoxide production
in 24-month GFP and LID mouse muscle fibers is a correlate
of decreased OCR (Fig. 2f).
Liver IGF-1 Deficiency Reduces Adipose Mass
and Increases Lipid Peroxidation
The GH/IGF-1 axis plays an important role in lipid metabo-
lism and homeostasis in organismal development and aging.
IGF-1 stimulates preadipocyte differentiation but has a limited
effect on mature adipocytes [56]. However, partial IGF-1 de-
ficiency decreases expression of genes involved in lipid me-
tabolism [57]. To determine the effect of reduced circulating
IGF-1 on lipid metabolism, we measured both subcutaneous
fat mass and epididymal fat mass and mitochondrial function.
Fat mass accumulates with age in the epididymal (eWAT) and
subcutaneous white adipose tissue (sWAT) fat pads expressed
as absolute levels or after normalized to body mass, but mice
deficient in IGF-1 were resistant to this change (Fig. 3a, b).
However, we observed no change in the ratio between visceral
(eWAT) to subcutaneous (sWAT) fat pads (Fig. 3c).
We simultaneously probed oxygen consumption rate
(OCR) and hydroperoxide production rate in eWAT using
O2K HRR (Fig. 3d, e). We observed no age-related change
in LEAK state or ETC complex I-stimulated respiration;
however, CI&CII (OXPHOS capacity), CII, and CIV-
linked respiration were decreased with age (Fig. 3d).
IGF-1-deficient animals had a modest (~ 20%) increase
in respiration under these states compared with 6-month
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WT. We observed a trend between both decreased
OXPHOS capacity and complex IV-linked respiration with
increased normalized eWAT mass suggesting eWAT OCR
is decreased by the age-related increase in visceral fat pad
mass (Fig. 3f, g). Surprisingly, aging was associated with
decreased hydroperoxide production detected by Amplex
UltraRed; additionally, the ETC inhibitors rotenone and
antimycin A did not increase Amplex UltraRed reaction
rate (Fig. 3e). IGF-1-deficient animals have a modest (~
10–30%) increase in Amplex UltraRed reaction rate under
these conditions. Because the inhibitors rotenone and
antimycin A did not increase the Amplex UltraRed reac-
tion rate as seen in other tissues, we concluded that the
source of the reactants may not originate from the ETC.
Furthermore, there were no significant differences between
hydroperoxide production as a percentage of OCR, sug-
gesting that the decline in hydroperoxide production rate
is caused by the decline in OCR (Fig. 3h).
Fig. 2 IGF-1 deficiency does not alter age-related changes in muscle
mass or mitochondrial function. Decrease in a raw muscle mass and b
muscle mass normalized to body mass in gastrocnemius and quadriceps
femorismuscles from 24-monthGFP and LIDmice compared to 6-month
WT (n = 6). Simultaneous c oxygen consumption rate (OCR) and d
hydroperoxide production rate (ROS) in permeabilized red gastrocnemius
fibers from 6-month WT, 24-month GFP, and 24-month LID mice mea-
sured in the O2K with Amplex UltraRed and normalized to wet fiber
mass (n = 6). e Linear regression between gastrocnemius fiber
OXPHOS capacity and normalized gastrocnemius mass. f Amplex
UltraRed Reaction Rate (ROS) as a percentage of oxygen consumption
rate (OCR) in gastrocnemius fibers. Statistical significance determined by
ordinary one-way ANOVAwith Tukey’s Multiple Comparison Test (*p <
0.05). Box plots depicted as mean ± SEM. Six-month WT (black); 24-
month GFP (green); 24-month LID (blue). Glutamate (Glu); malate
(Mal); adenosine diphosphate (ADP); rotenone (Rot); ascorbate (Asc);
N,N,N′,N′-tetramethyl-p-phenylenediamine dihydrochloride (TMPD);
antimycin A (AmA); ETC complex I (CI); ETC complex II (CII); ETC
complex IV (CIV)
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We also measured the ratio of reduced (GSH) to oxidized
(GSSG) glutathione and lipid peroxides as markers of oxidative
stress in 6-month WT, 24-month GFP, and 24-month LID
eWAT. The glutathione antioxidant system is composed of an-
tioxidant enzymes that use the reduced form of glutathione
(GSH) as a co-factor to repair oxidative damage by reducing
disulfide bonds [58]. We found no difference in GSH, GSSG,
or GSSG ratio between the groups (Supplemental Table 1). F2-
isoprostanes are a reliablemarker of lipid peroxidation, which is
formed by free radical reaction with arachidonic acid [40]. We
found a significant increase in F2-isoprostanes in 24-month LID
eWAT compared with eWAT from aged GFP (Fig. 3i,
Supplemental Table 1). Thus, circulating IGF-1 deficiency in-
duced oxidative damage related to lipid species in eWAT irre-
spective of increased lipid metabolism.
Circulating IGF-1 Deficiency Impairs
Hippocampal-Dependent Spatial Learning
IGF-1 has pleiotropic effects on many tissues and cell types
that vary between the sexes and tissue type [14, 16, 17].
Lifelong GH/IGF-1 deficiency has been shown to increase
Fig. 3 IGF-1 protects against age-related increase in adipose mass and
decrease in adipose mitochondrial function. Change in a raw fat mass and
b fat mass normalized to body mass in epididymal white adipose tissue
(eWAT) and subcutaneous white adipose tissue (sWAT) fat pads, c and
ratio of visceral (eWAT) to subcutaneous (sWAT) fat from 24-month GFP
and LID mice compared with 6-month WT (n = 6). Simultaneous d
oxygen consumption rate (OCR) and e hydroperoxide production rate
(ROS) production in eWAT sections from 6-month WT and 24-month
GFP and LID mice measured in the O2K with Amplex UltraRed and
normalized to wet tissue mass (n = 6). Linear regression between f
eWAT OXPHOS Capacity and normalized eWAT mass and g CIV
OCR and normalized eWAT mass (n = 6). h eWAT Amplex UltraRed
Reaction Rate (ROS) as a percentage of oxygen consumption rate (OCR)
(n = 6). i Lipid hydroperoxides measured using F2-isoprostanes in eWAT
from 6-month WT and 24-month GFP and LID mice (n = 6). Statistical
significance determined by ordinary one-way ANOVA with Tukey’s
Multiple Comparison Test (*p < 0.05). Box plots depicted as mean ±
SEM. 6-month WT (black); 24-month GFP (green); 24-month LID
(blue). Glutamate (Glu); malate (Mal); adenosine diphosphate (ADP);
rotenone (Rot); ascorbate (Asc); N,N,N ′ ,N ′-tetramethyl-p-
phenylenediamine dihydrochloride (TMPD); antimycin A (AmA); ETC
complex I (CI); ETC complex II (CII); ETC complex IV (CIV)
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lifespan in many models including mice [59–63]. However,
late life IGF-1 deficiency (relevant to humans) has only a
modest effect on maximum lifespan in female but not in male
mice, in part, by reducing cancer risk [14]. Numerous studies
have shown that IGF-1 is neuroprotective and has pro-
cognitive effects. To determine the impact of reduced serum
IGF-1 on cognitive function, we tested control and LID mice
in a radial arm water maze for hippocampal-dependent spatial
learning and memory. Mice (18 months) were placed in the
water maze and allowed to find a hidden platform and move-
ment parameters were recorded (path length, etc.). LID mice
took a longer path length (distance travelled; Fig. 4a) to find
the platform over the 3-day period (acquisition) compared
with controls (GFP). The slope of the lines also indicates that
the LID mice are less efficient at acquiring the task compared
with controls. LID mice also made more entries into incorrect
arms (errors; Fig. 4b) and had a longer duration in incorrect
arms (Fig. 4c) compared with controls. Time (s) to reach the
target (latency) was also reduced in LID mice (Fig. 4d), while
no differences were observed in the overall velocity to reach
the target between the groups. Representative heat maps of
mice (Fig. 4h; control and LID) illustrate the increased path
length and errors taken to reach the target arm in LID mice
compared with controls after the third day of training.
Following acquisition, mice were tested for memory of the
hidden platform on day 10. No differences were observed
between the groups (Fig. 4f) in the animals’ ability to remem-
ber the location of the hidden platform (probe). On day 11,
when the platform was switched to a new location, LID mice
made more errors to reach the platform (Fig. 4g), suggesting
that the LID mice are impaired in their ability to learn the new
task.
Decline in Circulating IGF-1 Decreases Brain
Mitochondrial Efficiency and Increases Stress
Response and Oxidative Damage
IGF-1 has been shown to induce alterations in mitochondrial
function [32] and protect against oxidative stress via sustained
AKTactivation [29, 30]. To assess mitochondrial function, we
isolated mitochondria from 18-month GFP and LID hippo-
campi and measured oxygen consumption rate (OCR) and
hydroperoxide production rate using O2K HRR. While we
observed no significant difference in OCR, there is a modest
increase in LEAK respiration and a decrease in OXPHOS
capacity from isolated mitochondria from LID hippocampus
resulting in decreased OXPHOS coupling efficiency (Fig.
5a, b). We observed no difference in hydroperoxide produc-
tion rate, though there is a non-significant increase in hydro-
peroxide production capabilities with rotenone and antimycin
A in LID hippocampus isolated mitochondria (Supplemental
Figure 2A). After addition of rotenone, we observed a trend
for an increase (p < 0.1) in hydroperoxide production as a
percentage of oxygen consumed in 18-month LID cortex
compared with GFP (Supplemental Figure 2B). We next
asked how impaired hippocampus mitochondrial coupling ef-
ficiency would impact cellular energetics, so we measured
concentrations of central energy metabolites in cortex of
young and 18-month GFP and LID mice (Supplemental
Table 1). Consistent with a decrease inmitochondrial coupling
efficiency, we also observed a decrease in ATP concentrations
in cortex from 18-month LID mice compared with GFP (Fig.
5d, Supplemental Table 1). However, no differences in NAD+
, NADH, NADP+, NADPH, or the NAD+/NADH ratio were
found (Supplemental Table 1). The NADP+/NADPH ratio
was increased in 18-month GFP mice (Fig . 5c ,
Supplemental Table 1). Energy charge ratio, a measure of
phosphorylated (ATP and ADP) versus total (ATP, ADP,
AMP) adenosine, was also not significantly different
(Supplemental Table 1) [33]. However, the decrease in mito-
chondrial coupling efficiency and ATP content in 18-month
LID mice suggested a decrease in energetic capability in IGF-
1-deficient brains.
Protein from hippocampi of 18-month GFP and LID mice
was isolated and targeted proteomics analysis was performed
to measure how impaired energy production affects protein
content of central metabolic and stress response pathways
(Supplemental Table 2). No individual protein measured
passed our false discovery rate (FDR) threshold (p < 0.05)
(Fig. 5e). Of the proteins measured, most were increased in
expression in LID mice (69 increased versus 17 decreased)
and higher variability was seen in principal component anal-
ysis (PCA) of LID compared with GFP mice (Fig. 5e, f).
Increased variability in LID mice protein is consistent with
the concept of increased age-related heterogeneity [64].
Finally, oxidative stress was assessed in the cortex using the
glutathione ratio, lipid peroxides, and protein carbonyls. We
found no differences in the individual concentrations of reduced
(GSH) or oxidized glutathione (GSSG), but we did observe a
non-significant increase in the GSH/GSSG ratio in 18-month
LIDmice as well as a statistically significant increase in variabil-
ity (Bartlett’s test p < 0.0001) (Fig. 5g, Supplemental Table 1).
We observed a significant increase in F2-isoprostane concentra-
tion in cortex from aged LIDmice compared with young and old
controls (Fig. 5h). Previous reports indicate that oxidative dam-
age to proteins can cause the formation of protein carbonyls [65],
andwe found a significant increase in protein carbonyls in cortex
from 18-month LID mice compared with GFP mice (Fig. 5i,
Supplemental Figure 2A, B).
Discussion
The highly conserved insulin/IGF pathway has been exten-
sively studied [14, 66–72] in the context of aging and neuro-
degeneration [11, 73]. While early evidence suggested that
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lower levels of IGF-1 were beneficial for lifespan, recent ex-
tensive studies indicate that these findings were limited to
C. elegans and drosophila that exhibit common insulin/IGF-
1 receptor pathways [15]. In mammals, the effects of IGF-1
are both tissue and sex specific [11, 14–17, 74]. Furthermore,
prevailing evidence suggests that age-related deficiency in
IGF-1 is associated with cognitive impairment, vascular rare-
faction [70], and diminished clearance of amyloid β (Aβ)
[75–78]. We have previously shown that reduced IGF-1
signaling in astrocytes impairs mitochondrial metabolism
and working memory [32]. In light of the controversy of the
central and peripheral effects of IGF-1, we investigated
whether these effects are mediated through the modulation
of mitochondrial function. In this study, we show that circu-
lating IGF-1 deficiency has varied effects on peripheral and
brain energy metabolism that manifests as a decline in cogni-
tive function but in contrast has marginal effects on peripheral
mitochondrial function.
Fig. 4 Circulating IGF-1 deficiency impairs hippocampal-dependent spa-
tial acquisition and extinction. Mice (control and LID) were tested in the
RAWM for spatial memory with 8 trials per day for 3 days (days 1–3
acquisition). One week post acquisition (day 10), mice were tested for
memory of the learned target location (probe) followed by a reversal
learning (extinction) of a new target location on day 11. During the ac-
quisition phase, LID mice show increased path length to reach target (a),
increased entries (b), and duration (c) into incorrect arms (errors)
compared with controls. LID mice also show increased latency (d), albeit
there were no differences in velocity between groups (e). fMemory of the
learned target tested on day 10 was not different between groups. g LID
mice made significantly more errors during reversal learning compared
with controls. h Representative heat maps at the end of the third day of
acquisition show that LID mice make more errors in spatial learning as
measured by the aforementioned parameters
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Loss of muscle mass/sarcopenia is a primary component of
frailty and morbidity in aged individuals. Both insulin and
IGF-1 are potent regulators of protein synthesis, muscle me-
tabolism, and growth through shared downstream signaling
pathways [79–86]. Our data showed no differences in muscle
mitochondrial oxygen consumption rate in LID mice at 24
months of age compared with age-matched controls, although
muscle mass and OXPHOS capacity declined with age as
expected. Consistent with previous reports [34], hydroperox-
ide production was unaffected with age or with reduced
Fig. 5 Reduction in circulating IGF-1 levels decreases brain mitochon-
drial efficiency and increases stress response and oxidative damage. a
Oxygen consumption rate (OCR) and b OXPHOS coupling efficiency
(1 – LEAK/OXPHOS Capacity) of hippocampus mitochondria isolated
from 18-month GFP and LID mice measured in the O2K with Amplex
UltraRed and normalized to μg mitochondrial protein (n = 8–10). c
NADP+/NADPH ratio and d ATP concentration of cortex from 6-
month WT and 18-month GFP and LID (n = 5–8). e Relative protein
abundance and f principal component analysis (PCA) of metabolic and
stress response proteins of isolated cortex protein from 18-month GFP
and LID mouse brains by targeted mass spectrometry and selected reac-
tion monitoring (n = 6). g Ratio of reduced (GSH) to oxidized (GSSG)
glutathione and h level of F2-isoprostanes in the cortex of 6-month WT
and 18-month GFP and LID mice (n = 5–8). i Protein carbonylation
(FITC conjugated) normalized to Coomassie gel staining in the cortex
of 18-month GFP and LID mice (n = 7–9). Statistical significance for
experiments with two groups determined by two-tailed student’s t test (*p
< 0.05), and statistical significance for experiments with three groups
determined by ordinary one-way ANOVAwith Tukey’s multiple compar-
ison test (*p < 0.05). Box plots depicted as mean ± SEM. Six-month WT
(black); 18-month GFP (green); 18-month LID (blue). Glutamate (Glu);
malate (Mal); adenosine diphosphate (ADP); rotenone (Rot); ascorbate
(Asc); N,N,N′,N′-tetramethyl-p-phenylenediamine dihydrochloride
(TMPD); antimycin A (AmA); ETC complex I (CI); ETC complex II
(CII); ETC complex IV (CIV)
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circulating IGF-1. These data suggest that reduced circulating
IGF-1 levels did not alter the age-related decline in muscle
mass. However, these effects may need to be functionally
characterized in these mice using exercise/stimulation of skel-
etal muscle to detect capacity for hypertrophy since muscle-
specific overexpression of IGF-1 has been shown to prevent
age-related atrophy and myopathies [44, 87]. Surprisingly, we
found a decrease in hydroperoxides produced by aged GFP
and LID mice. However, when hydroperoxide production is
represented as a proportion of oxygen consumed, we find no
difference with age. This suggests that the age-related de-
crease in hydroperoxides is related to the decline in oxygen
consumption rates and is not caused by an increase or decrease
in rates of electrons forming reactive oxygen species from the
electron transport chain (ETC). Furthermore, when we added
electron transport chain inhibitors, we saw no difference in
capacity to produce hydroperoxides with age, which was re-
cently reported in human muscle biopsies [88].
Growth hormone levels are reported to increase both fat
metabolism and insulin resistance [47–49, 89, 90]. We have
previously reported that circulating IGF-1 deficiency results in
a compensatory rise in GH levels [14]. In accordance with
these reports, LID mice are insulin resistant, display increased
fat metabolism, and have reduced fat mass. While GH has
direct lipolytic effects on mature adipocytes, IGF-1 adminis-
tration in GH-deficient human subjects synergistically in-
creased lipid oxidation in combination with GH supplemen-
tation [91]. Thus, reduced circulating IGF-1 levels may aug-
ment the effects of GH on fat mobilization. While muscle
respiration depends on electrons entering the electron trans-
port chain from both complexes I and II, fat mitochondria
depend primarily on complex II-linked respiration. ETC com-
plex II is highly sensitive to oxidative damage, which could
partially explain the age-related decrease in OXPHOS capac-
ity [92]. Basal hydroperoxide production was approximately
4.5 times higher in fat biopsies than in muscle. However,
because this rate did not increase with addition of electron
transport chain inhibitors, it is likely that the source of the
hydroperoxides is not the electron transport chain. These basal
hydroperoxides interacting with Amplex UltraRed could be
hydrogen peroxide derived from NAD(P)H oxidases via pro-
duction of superoxide anions or by reaction with lipid perox-
ides [36, 93].
The effects of GH/IGF-1 on lifespan/health span have
remained controversial especially related to peripheral and
central tissue functions. Mouse models of early life GH/IGF-
1 deficiency are reported to have beneficial effects on health
span and lifespan [94, 95]. However, the confounding effects
of altered development and compensatory mechanisms that
promote survival in the early life GH/IGF-1-deficient models
impair interpretation and their significance for aging/health
span effects. Adult-onset IGF-1/IGFR deficiency have mini-
mal effects on lifespan in males and increases lifespan in
females [14, 96]. We previously reported that the adult-onset
liver-IGF-1-deficient (LID) mice displayed a significant de-
cline in spatial learning assessed by the Barnes maze [14]. Our
current data support these previous findings in that LID mice
have significant impairments in spatial learning and reversal
learning, but recall of a learned memory is not affected. These
data suggest that initial processing by the hippocampus in
consolidation is sensitive to reduced circulating IGF-1 levels.
Reversal learning is the animal’s ability to forget the previous
location and learn the platform location. Reversal learning in
mice has been evaluated in a variety of behavioral tasks, in-
cluding spatial learning with Morris water maze, T-maze [97],
and eight arm maze [98]. In our study, LID mice exhibited a
deficit in reversal learning that is indicative of a dysfunction in
the coordinated actions of these brain regions associated with
reversal learning such as the orbitofrontal cortex, dorsal stria-
tum, and amygdala [99–103].
These data are consistent with reports that have shown
beneficial cognitive effects from GH/IGF-1 replacement [10,
54, 66, 73, 104, 105]. Additionally, GH-deficient mice have
reduced hippocampal ATP levels, which is improved upon
GH/IGF-1 replacement [31]. More recently, overexpression
of IGF-1 centrally has been shown to protect against age-
related cognitive dysfunction in male mice [106].
Interestingly, central IGF-1 administration has also been
shown to improve peripheral insulin action [107]. Low doses
of IGF-1 have also shown to improve liver mitochondrial
function in aging rats [53]. Our data show reduced hippocam-
pal OXPHOS coupling efficiency and brain ATP levels in LID
mice with a concomitant increase in oxidative damage in the
brain that may underlie the cognitive deficits in this model.
These data provide further support for the concept that IGF-1
has beneficial effects in the brain with varied peripheral ef-
fects. Future studies examining mitochondrial metabolism in
various brain regions of IGF-1-deficient mice will be impor-
tant to understand the role of regional differences in energy
metabolism on cognitive function.
In conclusion, we have shown that the effects of IGF-1 are
multifaceted. Certainly, much of the evidence in the literature,
which is supported by our own findings, suggests that IGF-1 is
protective for cognitive function, and that there exists an ap-
parent dichotomy between the systemic and central regulation
of IGF-1 actions. Thus, the evolutionary advantage of reduced
peripheral IGF-1 and increased lifespan with respect to re-
duced cancer incidence and progression may be offset by a
central deficit that serves minimal evolutionary impact.
Furthermore, IGF-1 effects on energy metabolism appear to
underlie, in part, the differences between the central and pe-
ripheral effects of IGF-1. Therefore, resolution of the contro-
versies underlying IGF-1 signaling between invertebrate and
mammalian models can be achieved only through rigorous
investigation of downstream signaling pathways in a tissue/
cell-specific manner.
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